Patrick Round

640 total citations
8 papers, 500 citations indexed

About

Patrick Round is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick Round has authored 8 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick Round's work include Cardiac electrophysiology and arrhythmias (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Patrick Round is often cited by papers focused on Cardiac electrophysiology and arrhythmias (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Patrick Round collaborates with scholars based in United Kingdom, United States and Netherlands. Patrick Round's co-authors include J. Ford, John J.P. Kastelein, G. Kees Hovingh, Sander J. H. van Deventer, Daniel J. Rader, H. Bryan Brewer, Danish Saleheen, Philip J. Barter, Jan Robinson and Huda Badri and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and British Journal of Clinical Pharmacology.

In The Last Decade

Patrick Round

8 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Round United Kingdom 7 235 139 137 120 119 8 500
Melvin J. Tonkon United States 11 112 0.5× 101 0.7× 351 2.6× 42 0.3× 40 0.3× 22 548
Lisa Semeniuk Canada 10 122 0.5× 52 0.4× 441 3.2× 104 0.9× 46 0.4× 11 757
Oreste Arcucci Italy 8 122 0.5× 71 0.5× 232 1.7× 69 0.6× 37 0.3× 10 458
Jean Firth South Africa 13 526 2.2× 188 1.4× 140 1.0× 13 0.1× 62 0.5× 23 670
Ken Kanamasa Japan 12 101 0.4× 26 0.2× 293 2.1× 76 0.6× 26 0.2× 59 435
Charlotte A. Baidoo United States 12 53 0.2× 18 0.1× 91 0.7× 148 1.2× 60 0.5× 17 395
Shigeru Kiyama Japan 8 66 0.3× 84 0.6× 123 0.9× 45 0.4× 71 0.6× 22 461
Nam‐Ho Kim South Korea 11 85 0.4× 33 0.2× 120 0.9× 67 0.6× 17 0.1× 23 363
Giuseppe Armentaro Italy 14 52 0.2× 90 0.6× 222 1.6× 92 0.8× 64 0.5× 56 453
Iris Postmus Netherlands 14 188 0.8× 111 0.8× 60 0.4× 112 0.9× 13 0.1× 18 483

Countries citing papers authored by Patrick Round

Since Specialization
Citations

This map shows the geographic impact of Patrick Round's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Round with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Round more than expected).

Fields of papers citing papers by Patrick Round

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Round. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Round. The network helps show where Patrick Round may publish in the future.

Co-authorship network of co-authors of Patrick Round

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Round. A scholar is included among the top collaborators of Patrick Round based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Round. Patrick Round is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Belvisi, Maria G., Mark A. Birrell, Michael A. Wortley, et al.. (2017). XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough. American Journal of Respiratory and Critical Care Medicine. 196(10). 1255–1263. 121 indexed citations
3.
Capelleveen, Julian C. van, John J.P. Kastelein, Aeilko H. Zwinderman, et al.. (2016). Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses. Journal of clinical lipidology. 10(5). 1137–1144.e3. 33 indexed citations
4.
Hovingh, G. Kees, John J.P. Kastelein, Sander J. H. van Deventer, et al.. (2015). Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet. 386(9992). 452–460. 176 indexed citations
5.
Ford, John W., J. Milnes, Erich Wettwer, et al.. (2015). The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation. Heart Rhythm. 13(2). 555–564. 52 indexed citations
6.
Ford, J., D. E. Fowler, Nobuko Maruyama, et al.. (2014). Tolerability, pharmacokinetics and pharmacodynamics of TA‐8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. British Journal of Clinical Pharmacology. 78(3). 498–508. 43 indexed citations
7.
Fossa, Anthony A., et al.. (2013). Use of Continuous ECG for Improvements in Assessing the Standing Response as a Positive Control for QT Prolongation. Annals of Noninvasive Electrocardiology. 19(1). 82–89. 4 indexed citations
8.
Round, Patrick, et al.. (2011). An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN‐D0501 in healthy subjects. British Journal of Clinical Pharmacology. 72(6). 921–931. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026